Latest News
RegulatoryConnect The MHRA’s new ‘Front Door’
The MHRA have made the first release of their RegulatoryConnect service available which allows tracking of the submission status of product licence applications but will soon offer much more.
New Valproate safety measures
The Medicines and Healthcare products Regulatory Agency (MHRA) announced that from the 31st of January 2024 new regulatory measures have been implemented to ensure that the known harms associated with valproate use are reduced.
Codeine linctus to be reclassified to a prescription-only medicine
A press release from the MHRA today, 20th February 2024, has announced that Codeine linctus will be reclassified as a prescription only medicine because of the risk of abuse and addiction.